Walleye Capital logo

Walleye Capital

North America, Minnesota, United States, Plymouth

Description

Walleye Capital provides tailored investment strategies, hedge funds, risk management, and wealth management advisory services.

Investor Profile

Walleye Capital has made 14 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (29%)
  • Series C (21%)
  • Post Ipo Equity (14%)
  • Series D (14%)
  • Series G (7%)
  • Series E (7%)
  • Series F (7%)

Country Focus

  • United States (79%)
  • Belgium (14%)
  • Israel (7%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Saas
  • E-commerce
  • Oncology
  • Software
  • Artificial Intelligence (Ai)
  • Food And Beverage
  • Internet
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Walleye Capital frequently co-invest with?

Asabys Partners
Europe, Catalonia, Spain, Barcelona
Co-Investments: 2
CA
North America, Massachusetts, United States, Boston
Co-Investments: 2
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 2
Catalio Capital Management
North America, New York, United States, New York
Co-Investments: 2
Woodline Partners
North America, California, United States, San Francisco
Co-Investments: 3
T. Rowe Price
North America, Maryland, United States, Baltimore
Co-Investments: 3
Redmile Group
North America, California, United States, San Francisco
Co-Investments: 2
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 3
Colt Ventures
North America, Texas, United States, Dallas
Co-Investments: 2
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 4

Which angels does Walleye Capital often collaborate with?

ML
North America, California, United States, San Francisco
Shared Deals: 1
CE
Europe, Berlin, Germany, Berlin
Shared Deals: 2
BC
North America, California, United States, San Francisco
Shared Deals: 1
AT
North America, California, United States, Berkeley
Shared Deals: 1
IP
North America, California, United States, Mountain View
Shared Deals: 1

What are some of recent deals done by Walleye Capital?

Aardvark Therapeutics

San Diego, California, United States

Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders.

BiotechnologyHealth CareTherapeutics
Series CMay 9, 2024
Amount Raised: $85,000,000
Unicycive Therapeutics

Los Altos, California, United States

Unicycive Therapeutics provides development programs that focus on treating kidney diseases with unmet medical needs.

BiotechnologyHealth CareHealth DiagnosticsMedical
Post Ipo EquityMar 14, 2024
Amount Raised: $50,000,000
Odyssey Therapeutics

Cambridge, Massachusetts, United States

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

BiotechnologyHealth CareOncologyTherapeutics
Series CDec 5, 2023
Amount Raised: $101,000,000
AgomAb Therapeutics

Ghent, Oost-Vlaanderen, Belgium

AgomAb Therapeutics is a Company is developing growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues.

BiotechnologyHealth CareTherapeutics
Series COct 11, 2023
Amount Raised: $100,817,696
Odyssey Therapeutics

Cambridge, Massachusetts, United States

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

BiotechnologyHealth CareOncologyTherapeutics
Series BOct 13, 2022
Amount Raised: $168,000,000
GrubMarket

San Francisco, California, United States

GrubMarket is an AI-powered prominent B2B eCommerce business operating in the American food supply chain industry.

Artificial Intelligence (AI)E-CommerceFood and BeverageInternetPaymentsSaaSSupply Chain Management
Series FSep 28, 2022
Amount Raised: $120,000,000
Ventyx Biosciences

Encinitas, California, United States

Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.

BiopharmaBiotechnology
Post Ipo EquitySep 19, 2022
Amount Raised: $176,600,000
AgomAb Therapeutics

Ghent, Oost-Vlaanderen, Belgium

AgomAb Therapeutics is a Company is developing growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues.

BiotechnologyHealth CareTherapeutics
Series BJul 13, 2022
Amount Raised: $38,531,817
Clear Street

New York, New York, United States

Clear Street is a diversified financial services firm replacing the legacy infrastructure used across capital markets.

Cloud InfrastructureFinancial ServicesFinTech
Series BMay 24, 2022
Amount Raised: $165,000,000
Gauzy

Tel Aviv-yafo, Tel Aviv, Israel

Gauzy is a world leading vendor of material science focused on developing, manufacturing, and marketing LCG®(light control glass) technology

Customer ServiceManufacturingService Industry
Series DFeb 8, 2022
Amount Raised: $70,000,000